Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EYT
|
|||
| Drug Name |
N-(pyridin-2-yl)pyridine methylsulfone derivative 1
|
|||
| Synonyms |
PMID26161698-Compound-27
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BAYER PHARMA AKTIENGESELLSCHAFT
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17F2N3O3S
|
|||
| Canonical SMILES |
COC1=C(C=CC(=C1)F)C2=CC(=NC=C2F)NC3=NC=CC(=C3)CS(=O)(=O)C
|
|||
| InChI |
1S/C19H17F2N3O3S/c1-27-17-8-13(20)3-4-14(17)15-9-19(23-10-16(15)21)24-18-7-12(5-6-22-18)11-28(2,25)26/h3-10H,11H2,1-2H3,(H,22,23,24)
|
|||
| InChIKey |
VRHHAMWTRSVIEX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 - 2014).Expert Opin Ther Pat. 2015;25(9):953-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.